MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-12-2026
DexCom Total Current Liabilities 2011-2026 | DXCM
Annual Total Current Liabilities DexCom
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.14 B | 2.93 B | 1.56 B | 1.84 B | 721 M | 614 M | 360 M | 222 M | 139 M | 102 M | 66.9 M | 40.6 M | 32.1 M | 19.5 M | 14.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.93 B | 14.7 M | 720 M |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
1.71 B | $ 115.6 | 0.06 % | $ 35.1 B |  USA |
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Co-Diagnostics
CODX
|
3.54 M | $ 1.65 | -1.2 % | $ 2.19 M | USA |
 |
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
49.4 M | $ 24.8 | 1.39 % | $ 689 M | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M |  Israel |
 |
CareDx, Inc
CDNA
|
89.8 M | $ 21.22 | -0.05 % | $ 1.13 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
Illumina
ILMN
|
1.55 B | $ 127.82 | -0.05 % | $ 20.3 B | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 15.81 | -3.07 % | $ 478 M | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
Lantheus Holdings
LNTH
|
333 M | $ 84.53 | 0.24 % | $ 5.7 B | USA |
 |
Charles River Laboratories International
CRL
|
1.12 B | $ 170.09 | 0.19 % | $ 8.43 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
1.34 B | $ 417.28 | 1.64 % | $ 12 B | USA |
 |
Guardant Health
GH
|
303 M | $ 89.33 | 0.47 % | $ 11.2 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
5.1 M | $ 1.93 | -2.08 % | $ 8.54 M | USA |
 |
Senseonics Holdings
SENS
|
24.3 M | $ 7.17 | 1.7 % | $ 299 M | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
Soleno Therapeutics
SLNO
|
61.4 M | $ 52.75 | 0.05 % | $ 2.68 B | USA |
 |
QIAGEN N.V.
QGEN
|
512 M | - | - | $ 10.6 B |  Niderland |
 |
Neogen Corporation
NEOG
|
174 M | $ 9.51 | -0.37 % | $ 2.06 B | USA |
 |
Biomerica
BMRA
|
1.74 M | $ 2.15 | 0.7 % | $ 4.94 M | USA |
 |
Thermo Fisher Scientific
TMO
|
15.2 B | $ 467.93 | -0.35 % | $ 176 B | USA |
 |
National Research Corporation
NRC
|
36.6 M | $ 17.07 | -0.93 % | $ 382 M | USA |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 101.57 | -0.59 % | $ 8.38 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 263.9 | 0.06 % | $ 22 B | USA |
 |
Celcuity
CELC
|
44.2 M | $ 123.04 | 1.66 % | $ 5.75 B | USA |
 |
Twist Bioscience Corporation
TWST
|
91.4 M | $ 60.76 | -0.3 % | $ 3.63 B | USA |
 |
OpGen
OPGN
|
634 K | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
88.3 M | $ 8.57 | 3.44 % | $ 1.1 B | USA |
 |
Myriad Genetics
MYGN
|
134 M | $ 4.76 | -0.42 % | $ 441 M | USA |
 |
Natera
NTRA
|
310 M | $ 204.88 | 0.55 % | $ 20.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 196.9 | 0.35 % | $ 21.9 B | USA |
 |
Invitae Corporation
NVTA
|
108 M | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
1.33 B | - | -0.91 % | $ 14.7 B | USA |